跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,624 条关于
“X-linked Retinitis Pigmentosa”
全部
14,624
临床试验
10,193
药物
806
机构
87
资讯
3,538
9个月前
Beacon Therapeutics Initiates LANDSCAPE Trial for X-Linked Retinitis Pigmentosa Gene Therapy
去年
FDA Grants RMAT Designation to Gene Therapies for Retinitis Pigmentosa
去年
Phase 2 SKYLINE Trial Shows Promising Results for Gene Therapy in X-Linked Retinitis Pigmentosa
去年
Beacon Therapeutics Reports Promising Phase 2 Data for Gene Therapy in X-Linked Retinitis Pigmentosa
5个月前
MeiraGTx Reacquires Gene Therapy Botaretigene Sparoparvovec from Johnson & Johnson for X-linked Retinitis Pigmentosa Treatment
去年
Beacon Therapeutics' AGTC-501 Shows Sustained Safety and Efficacy in X-Linked Retinitis Pigmentosa Trial
去年
AAO 2024: Emerging Data in Retinal Therapies for Geographic Atrophy, Stargardt Disease, and Retinitis Pigmentosa
去年
Beacon Therapeutics Appoints Gene Therapy Veteran Dr. Daniel Chung as Chief Medical Officer
去年
Beacon Therapeutics' Laru-zova Shows Promise in Phase 2 Trial for XLRP
去年
Mobile Vision Clinics Enable Successful Rare Eye Disease Trial Enrollment During Pandemic
第 1 页，共 354 页
上一页
下一页
